R&D Systems Recombinant Mouse IL-31RA Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Applications: Binding Activity
Manufacturer: R&D Systems 1253IL050
DescriptionThe Recombinant Mouse IL-31 RA Fc Chimera Protein is derived from Sf 21 (stably transfected). The Recombinant Mouse IL-31 RA Fc Chimera Protein has been validated for the following applications: Binding Activity.
|>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Spodoptera frugiperda,Sf 21 (stably transfected)-derived mouse IL-31 RA protein, (N-terminus) Mouse IL-31RA (Val19-Ser503) Accession &Num; AAM27959.1 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|class I cytokine receptor, CRL3, CRL3Glmr, Cytokine receptor-like 3, GLMR, GLM-R, GLM-RMGC125346, GP130 like receptor, Gp130-like monocyte receptor, Gp130-like receptor, hGLM-R, IL-31 RA, IL-31 receptor subunit alpha, IL-31R subunit alpha, IL31RA, IL-31RAGPLCRL, IL-31R-alpha, interleukin 31 receptor A, interleukin-31 receptor subunit alpha, PRO21384, soluble type I cytokine receptor CRL3, ZcytoR17|
|Lyophilized from a 0.2 μm filtered solution in PBS.|
|12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Reconstitute at 500 μg/mL in PBS.|